Rivastigmine and Emerging Nanotechnological Strategies for Targeted Delivery: A Comprehensive Review.

Babar E, Ur Rehman A, Gul P, Arshad MS, Shah BA, Ahmed N

Open source

DOI
10.2174/0113816128498395261019115044
Published
2026 Oct 22
Container
Current pharmaceutical design
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0113816128498395261019115044,
  title = {Rivastigmine and Emerging Nanotechnological Strategies for Targeted Delivery: A Comprehensive Review.},
  author = {Babar E and Ur Rehman A and Gul P and Arshad MS and Shah BA and Ahmed N},
  year = {2026},
  journal = {Current pharmaceutical design},
  doi = {10.2174/0113816128498395261019115044},
  url = {https://doi.org/10.2174/0113816128498395261019115044}
}

RIS

TY  - JOUR
TI  - Rivastigmine and Emerging Nanotechnological Strategies for Targeted Delivery: A Comprehensive Review.
AU  - Babar E
AU  - Ur Rehman A
AU  - Gul P
AU  - Arshad MS
AU  - Shah BA
AU  - Ahmed N
PY  - 2026
JO  - Current pharmaceutical design
DO  - 10.2174/0113816128498395261019115044
UR  - https://doi.org/10.2174/0113816128498395261019115044
ER  - 

APA

E, B., A, U. R., P, G., MS, A., BA, S., & N, A. (2026). Rivastigmine and Emerging Nanotechnological Strategies for Targeted Delivery: A Comprehensive Review.. Current pharmaceutical design. https://doi.org/10.2174/0113816128498395261019115044

Source records